Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

Restrict the search for m nalidixic acid to a specific field?

Approximate Matches

33412
Any Name

33407
Standardized Name

9041
Display Name

5031
Related Substance Name

3007
Reference Text / Citation

1712
Note

1568
Protein Structural Modification Type

1567
Structural Modification Type

1003
Code Literal

919
WIKIPEDIA

710
Code Comments

635
Protein Structural Modification Substance Name

488
root_modifications_structuralModifications_molecularFragment_refPname

317
Monomer Substance Name

270
Reference URL

223
Relationship Comments

222
Mixture Component Name

104
Code URL

97
JECFA EVALUATION

91
root_modifications_agentModifications_agentSubstance_refPname

Showing 1151 - 1160 of 39119 results

First page
Previous page
Next page
Next page

APD-209

VBU6DO3S24

Search for Structure

Status:

Investigational

Source:

NCT01977443: Phase 2 Interventional Completed Viral Conjunctivitis

(2013)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT01977443

Class (Stereo):

CHEMICAL (ABSOLUTE)

YOHIMBINE C-11

7G5I8N2S10

Search for Structure

Status:

Investigational

Source:

NCT03520543: Phase 1 Interventional Completed Healthy Controls

(2018)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT03520543

Class (Stereo):

CHEMICAL (ABSOLUTE)

VEBICORVIR

16F6055SMG

Search for Structure

Status:

Investigational

Source:

INN:vebicorvir [INN]

Source URL:

https://ginas.ncats.nih.gov/ginas/app/substance/16F6055SMG

Class (Stereo):

CHEMICAL (ACHIRAL)

AZD-5991

E3T5XXY9HX

Search for Structure

Status:

Investigational

Source:

NCT03218683: Phase 1 Interventional Terminated Relapsed or Refractory Acute Myeloid Leukemia (AML)

(2017)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT03218683

Class (Stereo):

CHEMICAL (ACHIRAL)

PYRUVIC ACID 2-C-13

8C0WTU2O92

Search for Structure

Status:

Investigational

Source:

NCT03502967: Early Phase 1 Interventional Enrolling by invitation Traumatic Brain Injury

(2018)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT03502967

Class (Stereo):

CHEMICAL (ACHIRAL)

REVOSIMELINE

9GHO88L89C

Search for Structure

Status:

Investigational

Source:

INN:revosimeline [INN]

Source URL:

https://ginas.ncats.nih.gov/ginas/app/substance/9GHO88L89C

Class (Stereo):

CHEMICAL (ACHIRAL)

AZD-5153

C7C7U6YEAO

Search for Structure

Status:

Investigational

Source:

NCT03013998: Phase 1/Phase 2 Interventional Recruiting Previously Untreated Acute Myeloid Leukemia

(2016)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT03013998

Class (Stereo):

CHEMICAL (ABSOLUTE)

Targets:

Bromodomain-containing protein 4

FAMT

BI3A0TJ5AX

Search for Structure

Status:

Investigational

Source:

NCT03944096: Phase 2 Interventional Unknown status Rheumatoid Arthritis

(2019)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT03944096

Class (Stereo):

CHEMICAL (ABSOLUTE)

TBI-166

TY9R7N6MS5

Search for Structure

Status:

Investigational

Source:

NCT04670120: Phase 2 Interventional Unknown status Sensitive Pulmonary Tuberculosis

(2021)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT04670120

Class (Stereo):

CHEMICAL (ACHIRAL)

BMS-962212

VWJ4VVZ3OU

Search for Structure

Status:

Investigational

Source:

NCT03197779: Phase 1 Interventional Completed Thrombosis

(2013)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT03197779

Class (Stereo):

CHEMICAL (ABSOLUTE)

Structure of APD-209

ABSOLUTE

Structure of YOHIMBINE C-11

ABSOLUTE

Structure of VEBICORVIR

ACHIRAL

Structure of AZD-5991

ACHIRAL

Structure of PYRUVIC ACID 2-C-13

ACHIRAL

PYRUVIC ACID 2-C-13

Structure of REVOSIMELINE

ACHIRAL

Structure of AZD-5153

ABSOLUTE

Structure of FAMT

ABSOLUTE

Structure of TBI-166

ACHIRAL

Structure of BMS-962212

ABSOLUTE

Showing 1151 - 1160 of 39119 results

First page
Previous page
Next page
Next page

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1